Article info
PDFOriginal research
Epithelial–mesenchymal transition and cancer stem cell interactions in breast phyllodes tumours: immunohistochemical evaluation of EZH2, EZR, HMGA2, CD24 and CD44 in correlation with outcome analysis
- Correspondence to Dr Syed Salahuddin Ahmed, Anatomical Pathology, Singapore General Hospital Division of Pathology, Singapore 169856, Singapore; syed.salahuddin.ahmed{at}singhealth.com.sg
Citation
Epithelial–mesenchymal transition and cancer stem cell interactions in breast phyllodes tumours: immunohistochemical evaluation of EZH2, EZR, HMGA2, CD24 and CD44 in correlation with outcome analysis
Publication history
- Received August 28, 2020
- Revised December 21, 2020
- Accepted January 23, 2021
- First published February 24, 2021.
Online issue publication
April 20, 2022
Article Versions
- Previous version (24 February 2021).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2022. No commercial re-use. See rights and permissions. Published by BMJ.